All deployments

PharmaDeployment record

Evolent Health

AI-led operating model

47%revenue growth

Scale
$652.5 million in revenue for Q2
Function
operational efficiency
2026 revenue outlook
$2.6 billion to $2.7 billion
annualized revenue from oncology
$300 million
adjusted EBITDA guidance
$120 million to $135 million
expected revenue growth 2027
more than 25%

Source story

Evolent Bets on AI-Led Operations as It Raises 2026 Revenue Outlook

Evolent Health company profile →Pharma desk →

MachineCon USA · from AIM Media House

Where enterprise AI is decided

An invitation-led day for the CIOs, CDOs and Chief AI Officers who own enterprise AI strategy.

  • New York5th edition · 583 Park Avenue
  • Dallas1st edition

Register for MachineCon USASee MachineCon USA →

  • Keynote on the main stage, MachineCon New York 2025
  • AI150 award winners on stage, MachineCon New York 2025
  • At the tables, MachineCon New York 2025
  • Networking, MachineCon New York 2025